executive

Apollomics (NASDAQ:APLM) has announced an updated strategic focus for the clinical development of vebreltinib by focusing on NSCLC patients with Met Amplification, as well as changes to its executive leadership team. As a result of the updated strategic focus, and aligned with the Co.’s resource needs going forward, Sanjeev Redkar,Continue Reading

Justin Sullivan/Getty Images News Apple (NASDAQ:AAPL) is apparently receiving an observer role position on OpenAI’s board of directors, according to a report Tuesday afternoon by Bloomberg, which cited anonymous sources close to the situation. The position is going to Phil Schiller, a 30-year Apple veteran who currently leads the AppContinue Reading